Healthcare >> CEO Interviews >> October 26, 2004

Richard Otto – Corautus Genetics Inc (caq)

RICHARD E. OTTO is President and Chief Executive Officer of CorAutus Genetics Inc. Mr. Otto has spent the past 35 years in the cardiac therapy marketplace. As CEO, he reorganized CardioDymanics International Corporation, located in San Diego, California. A redefinition of the company's business plan and thoughtful reengineering of the Company's product offerings led to successful funding and a full NASDAQ relisting of the Company's stock. Recruiting and directing an experienced management team and multiple product introductions have made CDIC the leader in noninvasive measurement of critical cardiac function parameters. Mr. Otto was a consultant to the founder of WebMD and was instrumental in significant funding of the predecessor company to WebMD, Endeavor Technologies. Mr. Otto also served as a consultant to the Cardiac Rhythm Management division of St. Jude Medical. Mr. Otto's career includes key management positions with Cardiac Pacemakers Inc. (now a Guidant company). Mr. Otto was instrumental in the early AICD clinical trials and strategies. Activities included selection and recruitment of key clinical centers and investigators, as well as successful implementation of market strategies and business development. Mr. Otto also held positions at Intermedics, Inc., Medtronic Inc., and Eli Lilly and Company. Mr. Otto serves on the Georgia Board of Directors of the Juvenile Diabetes Foundation, and Leukemia Society. Mr. Otto was a semifinalist in the 1997 Entrepreneur of the Year Award for the Southern California Region. He received his BS degree in Chemistry from the University of Georgia. Profile
TWST: Give us a history of your company and the technology behind your


Mr. Otto: Corautus resulted from the merger of a private company,

Vascular Genetics, of which I was the CEO,